NEFL and Parkinson disease: Serum neurofilament light chain (sNfL), as a biomarker reflecting neurological damage, has been measured in various neurological diseases, such as Parkinson's, multiple sclerosis and amyotrophic lateral sclerosis, and has played a corresponding role in assessing disease severity and determining prognosis [14].